FDA 510(k)

EliA RNA Pol III

K号: K202541 · 2021-09-13

决定日期2021-09-13

产品代码NYO

咨询委员会抱歉，您提供的信息不完整，无法进行翻译。请提供完整的医疗设备监管文本，以便我能够进行准确的翻译。

决定实质等同

器械摘要

EliA RNA Pol III is the device name listed in this FDA 510(k) record. The listed applicant is Phadia AB. It received FDA 510(k) clearance on 2021-09-13 under 510(k) number K202541. The device is classified under product code NYO. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the EliA RNA Pol III?

EliA RNA Pol III is a medical device that received FDA 510(k) clearance on 2021-09-13. The listed applicant is Phadia AB. The 510(k) number is K202541.

When did EliA RNA Pol III receive FDA 510(k) clearance?

EliA RNA Pol III received FDA 510(k) clearance on 2021-09-13, under 510(k) number K202541.

Who is the listed applicant for EliA RNA Pol III?

The FDA 510(k) record lists Phadia AB as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for EliA RNA Pol III?

The FDA product code for EliA RNA Pol III is NYO.

列明Phadia AB为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。

K253367EliA CTD 13 屏幕检测 K212181ImmunoCAP 过敏原 f433，过敏原成分 rTri a 14 LTP，小麦，ImmunoCAP 过敏原 f416，过敏原成分 rTri a 19 Omega-5 谷蛋白，小麦，ImmunoCAP 过敏原 f449，过敏原成分 rSes i 1 芝麻籽 K210902EliA Ro52, EliA Ro60 K202540EliA Rib-P K202067EliA SmDP-S K200279ImmunoCAP 过敏原 o215，成分 nGal-alpha-1,3-Gal(alpha-Gal) 甲状腺球蛋白，牛

查看所有 23 个设备 →

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息，请务必参考官方记录。

器械摘要

常见问题

列明Phadia AB为申报人的其他记录

相关器械（代码：NYO）

官方来源